These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
724 related articles for article (PubMed ID: 7565543)
101. Trends in perinatal transmission of HIV/AIDS in the United States. Lindegren ML; Byers RH; Thomas P; Davis SF; Caldwell B; Rogers M; Gwinn M; Ward JW; Fleming PL JAMA; 1999 Aug; 282(6):531-8. PubMed ID: 10450714 [TBL] [Abstract][Full Text] [Related]
102. Withdrawal of Pneumocystis jirovecii prophylaxis in HIV-infected children under highly active antiretroviral therapy. Urschel S; Ramos J; Mellado M; Giaquinto C; Verweel G; Schuster T; Niehues T; Belohradsky B; Wintergerst U; AIDS; 2005 Dec; 19(18):2103-8. PubMed ID: 16284459 [TBL] [Abstract][Full Text] [Related]
103. Pneumocystis pneumonia--a retrospective study 1991-2001 in Gothenburg, Sweden. Mikaelsson L; Jacobsson G; Andersson R J Infect; 2006 Oct; 53(4):260-5. PubMed ID: 16403575 [TBL] [Abstract][Full Text] [Related]
104. Encephalopathy in children with perinatally acquired human immunodeficiency virus infection. Pediatric Spectrum of Disease Clinical Consortium. Lobato MN; Caldwell MB; Ng P; Oxtoby MJ J Pediatr; 1995 May; 126(5 Pt 1):710-5. PubMed ID: 7751993 [TBL] [Abstract][Full Text] [Related]
106. Discontinuing Pneumocystis jirovecii Pneumonia Prophylaxis in HIV-Infected Patients With a CD4 Cell Count <200 cells/mm3. Sidhu VK; Foisy MM; Hughes CA Ann Pharmacother; 2015 Dec; 49(12):1343-8. PubMed ID: 26358129 [TBL] [Abstract][Full Text] [Related]
107. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. Eldred LJ; Wu AW; Chaisson RE; Moore RD J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):117-25. PubMed ID: 9637576 [TBL] [Abstract][Full Text] [Related]
108. Comparative evaluation of naturally occurring Pneumocystis carinii pneumonia (PCP) and PCP despite primary chemoprophylaxis in patients with AIDS. Bonora S; Lanzafame M; Allegranzi B; Soldani F; Vento S; Cazzadori A; Di Perri G; Concia E J Infect; 1997 Sep; 35(2):201. PubMed ID: 9354363 [No Abstract] [Full Text] [Related]
109. Changes in hospital admissions pattern in patients with human immunodeficiency virus infection in the era of Pneumocystis carinii prophylaxis. Chien SM; Rawji M; Mintz S; Rachlis A; Chan CK Chest; 1992 Oct; 102(4):1035-9. PubMed ID: 1395739 [TBL] [Abstract][Full Text] [Related]
110. Pneumocystis carinii pneumonia: pitfalls of prophylaxis. Massie RJ; Cooper PJ; Van Asperen PP; McIntyre P J Paediatr Child Health; 1998 Oct; 34(5):477-9. PubMed ID: 9767516 [TBL] [Abstract][Full Text] [Related]
111. PCP prophylaxis in paediatric HIV infection: time for a change? Kovacs JA; Kovacs AA Lancet; 1994 Jul; 344(8914):5-6. PubMed ID: 7912309 [No Abstract] [Full Text] [Related]
112. Incidence of symptomatic urinary tract infections in HIV seropositive patients and the use of cotrimoxazole as prophylaxis against Pneumocystis carinii pneumonia. Evans JK; McOwan A; Hillman RJ; Forster GE Genitourin Med; 1995 Apr; 71(2):120-2. PubMed ID: 7744401 [TBL] [Abstract][Full Text] [Related]
113. Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy: secondary prophylaxis. Abgrall S; Matheron S; Le Moing V; Dupont C; Costagliola D; J Acquir Immune Defic Syndr; 2001 Feb; 26(2):151-8. PubMed ID: 11242182 [TBL] [Abstract][Full Text] [Related]
114. Patterns of morbidity and mortality in AIDS patients on Pneumocystis carinii prophylaxis who died during hospital admission: a report of 50 diseased patients. Hentzen BT; Schreij G Neth J Med; 1996 Sep; 49(3):101-5. PubMed ID: 8854672 [TBL] [Abstract][Full Text] [Related]
115. Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals. Jorde UP; Horowitz HW; Wormser GP AIDS; 1993 Mar; 7(3):355-9. PubMed ID: 8471198 [TBL] [Abstract][Full Text] [Related]
116. Preventing Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children: new guidelines for prophylaxis. CDC, US Public Health Service, and the Infectious Disease Society of America. Grubman S; Simonds RJ Pediatr Infect Dis J; 1996 Feb; 15(2):165-8. PubMed ID: 8822291 [No Abstract] [Full Text] [Related]
117. Discontinuation of primary Pneumocystis carinii prophylaxis after reconstitution of CD4 cell counts in HIV-infected children. Urschel S; Schuster T; Dunsch D; Wintergerst U; Hofstetter R; Belohradsky BH AIDS; 2001 Aug; 15(12):1589-91. PubMed ID: 11504999 [No Abstract] [Full Text] [Related]
118. Pneumocystis carinii pneumonia in Hong Kong: a 10 year retrospective study. Hui M; Kwok WT J Med Microbiol; 2006 Jan; 55(Pt 1):85-88. PubMed ID: 16388034 [TBL] [Abstract][Full Text] [Related]
119. Pneumocystis carinii pneumonia and cytomegalovirus infection in children with vertically acquired HIV infection. Williams AJ; Duong T; McNally LM; Tookey PA; Masters J; Miller R; Lyall EG; Gibb DM AIDS; 2001 Feb; 15(3):335-9. PubMed ID: 11273213 [TBL] [Abstract][Full Text] [Related]
120. Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis. Kaplan JE; Hanson DL; Navin TR; Jones JL J Infect Dis; 1998 Oct; 178(4):1126-32. PubMed ID: 9806044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]